Certa Therapeutics
PrivateLast Round
Early Funding
Jun 4, 2018
Total Funding Raised
$19.11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Certa Therapeutics is a biotechnology company that develops precision therapies for the treatment of fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Certa Therapeutics Comparables
Compare Certa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mediar Therapeutics | 83% | |
| Emerald Health Pharmaceuticals | 78% | |
| Pulmongene | 78% |
Certa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 4, 2018 |
Certa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Melbourne | Early Funding |
| Uniseed | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- Jun 24, 2026
Monthly visitors increased 58% MoM.
Certa Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Certa Therapeutics's valuation, stock price, and market status.
Is Certa Therapeutics a public or private company?
Certa Therapeutics is a private company.
What is the current stock price of Certa Therapeutics?
Certa Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Certa Therapeutics worth (valuation)?
Valuation information for Certa Therapeutics is not publicly available.
Can I buy Certa Therapeutics stock?
Certa Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Certa Therapeutics's last funding round?
Certa Therapeutics's most recent funding round was Early Funding on June 4, 2018.
Who are the main investors in Certa Therapeutics?
Key investors in Certa Therapeutics include University of Melbourne, Uniseed.
Will Certa Therapeutics IPO soon?
No public IPO plans have been announced for Certa Therapeutics.
How can I track Certa Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Certa Therapeutics's secondary market activity and sign up for updates.